GlassScriptPhysician profile
Rafael Olacio
NPI 1982915971
$9,256.91
in general payments reported to CMS, 2019-2025
55 companies · $2,907 in 2025
The $2,907 reported for 2025 was more than what 95% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $72.03 · 2022: $1,500 · 2023: $2,279 · 2024: $2,499 · 2025: $2,907.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,406 · Education: $279.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,405.84 |
| Education | $278.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $919.04 | 2022-2025 | Enhertu, Calquence, Tagrisso |
| Merck Sharp & Dohme LLC | $878.36 | 2022-2025 | Keytruda, Lynparza, Welireg |
| Novartis Pharmaceuticals Corporation | $745.70 | 2022-2025 | |
| Daiichi Sankyo INC. | $588.42 | 2022-2025 | Enhertu |
| Janssen Biotech, INC. | $461.43 | 2022-2025 | Erleada, Balversa, Darzalex |
| Genentech USA, INC. | $455.28 | 2022-2025 | Tecentriq, Venclexta, Polivy |
| Lilly USA, LLC | $380.06 | 2022-2025 | Verzenio, Jaypirca, Retevmo |
| Pfizer INC. | $368.90 | 2022-2025 | |
| Rigel Pharmaceuticals, INC. | $323.24 | 2022-2025 | Rezlidhia, Tavalisse, Gavreto |
| Astellas Pharma US INC | $274.12 | 2023-2025 | Xtandi, Xospata, Vyloy |
| Insmed, INC. | $268.98 | 2024-2025 | Arikayce |
| Genzyme Corporation | $260.74 | 2022-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $246.61 | 2022-2025 | Ninlaro, Vpriv, Fruzaqla |
| Aveo Pharmaceuticals, INC. | $242.86 | 2022-2025 | Fotivda |
| Celgene Corporation | $214.01 | 2022-2025 | Reblozyl, Opdualag, Pomalyst |
Show all 55 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $196.18 | 2022-2025 | |
| Gilead Sciences, INC. | $190.70 | 2023-2025 | Trodelvy |
| Eisai INC. | $186.63 | 2022-2025 | |
| Amgen INC. | $174.85 | 2022 | |
| Coherus Oncology, INC. | $165.28 | 2022-2025 | Loqtorzi |
| US Oncology Corporate, INC. | $143.22 | 2024 | |
| Abbott Laboratories | $122.94 | 2023 | Freestyle Libre 3 |
| Glaxosmithkline, LLC. | $107.42 | 2022-2025 | Ojjaara, Zejula, Jemperli |
| Sumitomo Pharma America, INC. | $107.33 | 2023 | Orgovyx |
| E.R. Squibb & Sons, L.L.C. | $107.16 | 2022-2025 | Opdualag |
| Array Biopharma INC | $103.30 | 2023-2025 | Braftovi, Mektovi, Tukysa |
| Regeneron Healthcare Solutions, INC. | $102.60 | 2023-2025 | Libtayo |
| Alexion Pharmaceuticals, INC. | $72.71 | 2022-2023 | Soliris |
| Ipsen Biopharmaceuticals, INC | $71.33 | 2023-2025 | Onivyde, Somatuline Depot |
| Geron Corporation | $55.33 | 2025 | Rytelo |
| Incyte Corporation | $55.29 | 2025 | Jakafi, Monjuvi |
| Myovant Sciences INC. | $53.66 | 2022 | |
| Myriad Genetic Laboratories, INC. | $50.00 | 2022 | |
| Horizon Therapeutics Plc | $47.14 | 2021 | |
| Blueprint Medicines Corporation | $45.94 | 2023-2024 | Ayvakit |
| Sobi, INC | $42.52 | 2022-2025 | |
| Janssen Pharmaceuticals, INC | $42.31 | 2021-2022 | |
| Jazz Pharmaceuticals INC. | $42.12 | 2023 | |
| Taiho Oncology, INC. | $40.92 | 2022-2024 | |
| Octapharma USA, INC. | $37.40 | 2023-2025 | Panzyga, Octagam Immune Globulin (Human) |
| Ferring Pharmaceuticals INC. | $26.11 | 2025 | Adstiladrin |
| Recordati_rare_diseases_inc. | $23.69 | 2023 | Sylvant |
| Azurity Pharmaceuticals, INC. | $23.43 | 2025 | Danziten |
| Pharmaand Gmbh | $20.86 | 2025 | Rubraca |
| Abbvie INC. | $19.96 | 2024 | |
| Sun Pharmaceutical Industries INC. | $19.32 | 2023 | Yonsa, Odomzo |
| Stemline Therapeutics INC. | $18.45 | 2025 | Orserdu |
| Mirati Therapeutics, INC. | $15.08 | 2023 | Krazati |
| Tersera Therapeutics LLC | $14.86 | 2024 | Xermelo |
| Pharmaessentia USA Corporation | $14.76 | 2025 | Besremi |
| Emd Serono, INC. | $14.36 | 2023 | Bavencio |
| Nestle Healthcare Nutrition INC. | $13.88 | 2022 | |
| Tempus Ai, INC | $13.68 | 2025 | Xt Cdx |
| Acrotech Biopharma INC. | $13.27 | 2023 | Beleodaq |
| Pharmacosmos Therapeutics INC. | $13.17 | 2023 | Monoferric |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rafael Olacio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.